Behzad Hajarizadeh, Joanne M Carson, Marianne Byrne, Jason Grebely, Evan Cunningham, Janaki Amin, Peter Vickerman, Natasha K Martin, Carla Treloar, Marianne Martinello, Andrew R Lloyd, Gregory J Dore
People in prison are at high risk of HCV given high injecting drug use prevalence. This study evaluated HCV incidence and associated injecting drug use characteristics in prison. The SToP-C study enrolled people incarcerated in four Australian prisons. Participants were tested for HCV at enrolment and then every 3-6 months (October-2014 to November-2019). Participants eligible for this analysis included those at-risk of HCV primary infection (anti-HCV negative) or re-infection (anti-HCV positive, HCV RNA negative) with follow-up assessment...
November 7, 2023: Journal of Viral Hepatitis